Cargando…
Baicalein, 7,8-Dihydroxyflavone and Myricetin as Potent Inhibitors of Human Ornithine Decarboxylase
Background: Human ornithine decarboxylase (ODC) is a well-known oncogene, and the discovery of ODC enzyme inhibitors is a beneficial strategy for cancer therapy and prevention. Methods: We examined the inhibitory effects of a variety of flavone and flavonol derivatives on ODC enzymatic activity, and...
Autores principales: | Liu, Yun-Chin, Liu, Yi-Liang, Hsieh, Ju-Yi, Wang, Chang-Hsu, Lin, Chi-Li, Liu, Guang-Yaw, Hung, Hui-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765794/ https://www.ncbi.nlm.nih.gov/pubmed/33348871 http://dx.doi.org/10.3390/nu12123867 |
Ejemplares similares
-
Determinants of the Differential Antizyme-Binding Affinity of Ornithine Decarboxylase
por: Liu, Yen-Chin, et al.
Publicado: (2011) -
Functional Roles of the Dimer-Interface Residues in Human Ornithine Decarboxylase
por: Lee, Chien-Yun, et al.
Publicado: (2014) -
Minimal Antizyme Peptide Fully Functioning in the Binding and Inhibition of Ornithine Decarboxylase and Antizyme Inhibitor
por: Hsieh, Ju-Yi, et al.
Publicado: (2011) -
Critical Factors in Human Antizymes that Determine the Differential Binding, Inhibition, and Degradation of Human Ornithine Decarboxylase
por: Hsieh, Ju-Yi, et al.
Publicado: (2019) -
Critical Factors Governing the Difference in Antizyme-Binding Affinities between Human Ornithine Decarboxylase and Antizyme Inhibitor
por: Liu, Yen-Chin, et al.
Publicado: (2011)